Patent · US Expired

Method of preparing a rapidly dissolving powder of crystalline cephalothin sodium for parenteral administration

US4132848A · kind A · utility

4Cited by
3References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 3, 1977
Grant dateJan 2, 1979
Priority date
Expiry dateNov 3, 1997

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/545
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Essentially crystalline cephalothin sodium for parenteral administration is prepared by a freeze-drying process wherein a (C.sub.1 -C.sub.3 alcohol or acetone)-water solution of cephalothin sodium containing from about 2 to about 10 percent of C.sub.1 -C.sub.3 alcohol or acetone by volume is chilled from room temperature to -20.degree. C., or below, preferably about -40.degree. C. over a 1-3 hour period and then warmed to from about -3.degree. C. to about -10.degree. C. and held for 3 hours or more, then cooled to -20.degree. C., or below, preferably about -40.degree. C., before subjecting said frozen solution to a high vacuum and a moderate amount of heat to sublime the frozen solvent therefrom. The resulting powder dissolves rapidly in acceptable pharmaceutical diluents. Alternatively, from about 2 to about 5 percent by weight of sodium bicarbonate, related to the amount of cephalothin sodium present, is added to the solution before freeze-drying.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.